Abstract
Vibrio cholerae neuraminidase (VCNA) is widely used in biochemical and medical research, in processes for preparing homogenous sialoconjugates, and in the pharmaceutical industry. Its production by non-toxigenic strains is quite desirable, in order to avoid the expensive safety measures. Here, we report the first method for highly effective production of a novel, purified V. cholerae extracellular neuraminidase from a non-toxigenic strain. The enzyme is highly active, and its properties, as well as the responsible gene nanH, are practically identical with those of the toxigenic strains. It cleaves α,2 → 3 and α,2 → 6 glycosidic bonds with highest affinity (K M 1.7 × 10−5 μM) for human transferrin. The deduced amino acid sequence of the enzyme reveals three binding sites for Ca2+ and one for sialic acid. The sequence analysis of the nanH gene, being the first for a V. cholerae non-O1 strain, shows 99 % identity with a new nanH allele of an O1 Vibrio strain. The simple laboratory technology for efficient production of the new VCNA is based on the use of common and cheap nutrient media and easily available inducer—glycomacropeptide. The rapid purification consists of salting-out and diethylaminoethanol (DEAE) and Q-Sepharose chromatography steps. Purified preparation contains no aldolase and protease, which gives the production scheme a great potential for industrial application.
Similar content being viewed by others
References
Traving, C., & Schauer, R. (1998). Cellular and Molecular Life Sciences, 54, 1330–1349.
Chen, X., & Varki, A. (2010). ACS Chemical Biology, 5, 163–176. doi:10.1021/cb900266r.
Vimr, E. R., Kalivoda, K. A., Deszo, E. L., & Steenbergen, S. M. (2004). Microbiology and Molecular Biology Reviews, 68, 132–153. doi:10.1128/MMBR.68.1.132-153.2004.
Corfield, T. (1992). Glycobiology, 2, 509–521. doi:10.1093/glycob/2.6.509.
Vande Velde, S. (2013). Dissertation for Master of Medicine in Medicine, Universiteit Gent, Faculty of Medicine and Health Sciences, 48 pp.
Vimr, E.R. (2013). ISRM microbiology. Article ID 816713, 26 pages doi:10.1155/2013/816713.
Ada, G. L., & French, E. L. (1961). Journal of General Microbiology, 24, 409–421.
Cuatrecasas, P., & Illiano, G. (1971). Biochemical and Biophysical Research Communications, 44, 178–184. doi:10.1016/S0006-291X(71)80175-4.
Kabir, S., Ahmad, N., & Ali, S. (1984). Infection and Immunity, 44, 747–749.
Crennell, S., Garman, E., Laver, G., Vimr, E., & Taylor, G. (1994). Structure, 2, 535–544.
Moustafa, I., Connaris, H., Taylor, M., Zaitsev, V., Jennifer, C. W., Milton, J. K., von Itzstein, M., & Taylor, G. (2004). Journal of Biological Chemistry, 279, 40819–40826. doi:10.1074/jbc.M404965200.
Singh, D. V., Matte, M. H., Matte, G. R., Jiang, S., Sabeena, F., Shukla, B. N., Sanyal, S. C., Huq, A., & Colwell, R. R. (2001). Applied and Environmental Microbiology, 67, 910–921.
Faruque, S. M., & Nair, G. B. (2002). Microbiology and Immunology, 46, 59–66. doi:10.1111/j.1348-0421.2002.tb02659.x.
Azman, A. S., Rudolph, K. E., Cummings, D. A., & Lessler, J. (2013). Journal of Infection, 66, 432–438. doi:10.1016/j.jinf.2012.11.013.
Kaper, J. B., Morris, J. G., & Levine, M. M. (1995). Clinical Microbiology Reviews, 8, 48–86.
Estrella, R. P., Whitelock, J. M., Roubin, R. H., Packer, N. H., & Karlsson, N. G. (2009). Methods in Molecular Biology, 534, 171–192. doi:10.1007/978-1-59745-022-5_13.
Marino, K., Bones, J., Kattla, J. J., & Rudd, P. M. (2010). Nature Chemical Biology, 6, 713–723. doi:10.1038/nchembio.437.
Noyla, D. E., Clark, B., O’Donnell, F. T., Atmar, R. L., Greer, J., & Demmler, G. J. (2000). Journal of Clinical Microbiology, 38, 1161–1165.
Kline, E.L. (2010). Methods and compositions for treating neoplasms. Patent № US 7,842,314 B2.
Kim, S., Oh, D.-B., Kang, H. A., & Kwon, O. (2011). Applied Microbiology and Biotechnology, 91, 1–15. doi:10.1007/s00253-011-3307-2.
Solá, R. J., & Griebenow, K. (2010). BioDrugs, 24, 9–21. doi:10.2165/11530550-000000000-00000.
Vertiev, Y. U. V., Ezepchuk, Y. U. V., Abrashev, I. R., Khorlin, A. Y. A., & Krasnova, I. N. (1975). Bioorganicheskaya Khimiya, 1, 1639–1645.
Abrashev, I., Velcheva, P., Nikolov, P., & Kourteva, J. (1980). Substrate for colorimetric determination of enzyme activity. Bulgarian patent N 47647/IIR.
Tullio, L.T., Karkle, E.N.L., & Cândido, L.M.B. (2007). Boletim do Ceppa, Curitiba, V. 25, N. 1, Jan./Jun. 2007.
Neelima, S. R., Rajput, Y. S., & Mann, B. (2013). Dairy Science and Technology, 93, 21–43. doi:10.1007/s13594-012-0095-0.
Berg, W., Gutschker-Gdaniec, G., & Schauer, R. (1985). Analytical Biochemistry, 145, 339–342.
Uchida, Y., Tsukada, Y., & Sugimori, T. (1977). Journal of Biochemistry, 82, 1425–1433.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., & Randall, R. J. (1951). Journal of Biological Chemistry, 193, 265–275.
Lineweaver, H., & Burk, D. (1934). Journal of the American Chemical Society, 56, 658–666. doi:10.1021/ja01318a036.
Figueiredo, S. C., Neves-Borges, A. C., & Coelho, A. (2005). Memórias do Instituto Oswaldo Cruz, 100, 563–569. doi:10.1590/S0074-02762005000600010.
Eneva, R., Engibarov, S., Strateva, T., Abrashev, R., & Abrashev, I. (2011). Canadian Journal of Microbiology, 57, 606–610. doi:10.1139/W11-042.
Kumar, S., Lindquist, I. E., Sundararajan, A., Rajanna, C., Floyd, J. T., Smith, K. P., Andersen, J. L., He, G., Ayers, R. M., Johnson, J. A., Werdann, J. J., Sandoval, A. A., Mojica, N. M., Schilkey, F. D., Mudge, J., & Varela, M. F. (2013). Genome Announcements, 1, e00227-12. doi:10.1128/genomeA.00227-12.
Chernova, I. A., Shagaeva, L. K., Lavrovskiĭ, S. N., Abrashev, I., & Velcheva, P. (1987). Prikladnaia Biokhimiia i Mikrobiologiia, 23, 843–847.
Abrashev, I., Dulguerova, G., Dolashka-Angelova, P., & Voelter, W. (2005). Journal of Biochemistry, 137, 365–371. doi:10.1093/jb/mvi053.
Abrashev, I., & Orozova, P. (2006). Zeitschrift für Naturforschung, 61, 434–438.
Uchida, Y., Tsukada, Y., & Sugimori, T. (1979). Journal of Biochemistry, 86, 1573–1585.
Newstead, S. L., Potter, J. A., Wilson, J. C., Xu, G., Chien, C.-H., Watts, A. G., Withers, S. G., & Taylor, G. L. (2008). J Biol Chem. doi:10.1074/jbc.M710247200.
Vimr, E. R., Lawrisuk, L., Galen, J., & Kaper, J. B. (1988). Journal of Bacteriology, 170, 1495–1504.
Heidelberg, J. F., Eisen, J. A., Nelson, W. C., Clayton, R. A., Gwinn, M. L., Dodson, R. J., Haft, D. H., Hickey, E. K., Peterson, J. D., Umayam, L., Gill, S. R., Nelson, K. E., Read, T. D., Tettelin, H., Richardson, D., Ermolaeva, M. D., Vamathevan, J., Bass, S., Qin, H., Dragoi, I., Sellers, P., McDonald, L., Utterback, T., Fleishmann, R. D., Nierman, W. C., & White, O. (2000). Nature, 406, 477–483.
Galen, J. E., Ketley, J. M., Fasano, A., Richardson, S. H., Wasserman, S. S., & Kaper, J. B. (1992). Infection and Immunity, 60, 406–415.
Drzeniek, R. (1973). Histochemical Journal, 5, 271–290.
Müller, H. E. (1973). Infection and Immunity, 8, 430–433.
Acknowledgments
This work was supported by grant G-2-02/05 from the Ministry of Education and Science, Science Research Fund, Bulgaria. We thank Mr. Dejan Draganov for providing 4MU-Neu5Ac substrate and research assistant Anna Bratchkova for the visualization of the native PAGE.
Author information
Authors and Affiliations
Corresponding author
Additional information
Stephan Andreas Engibarov holds a MS degree.
Penka Petrova holds a PhD degree and is an Associated professor of The Stephan Angeloff Institute of Microbiology.
Radoslav Abrashev holds a PhD degree.
Tanya Strateva, PhD, is the Associated professor of The Department of Microbiology, Medical University, Sofia.
Vera Kolyovska holds a PhD degree.
Ignat Abrashev, PhD, is the Professor, DSc of The Stephan Angeloff Istitute of Microbiology.
Rights and permissions
About this article
Cite this article
Eneva, R.T., Engibarov, S.A., Petrova, P. et al. High Production of Neuraminidase by a Vibrio cholerae Non-O1 Strain—the First Possible Alternative to Toxigenic Producers. Appl Biochem Biotechnol 176, 412–427 (2015). https://doi.org/10.1007/s12010-015-1584-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-015-1584-4